Phenytoin increases 65zinc absorption in the rat

Area of Science:

• Pharmacology and Toxicology
• Nutritional Science
• Mineral Metabolism

Background:

• Zinc is an essential trace element crucial for numerous physiological processes.
• Phenytoin is a widely used antiepileptic drug with known interactions with various nutrients.
• Understanding drug-nutrient interactions is vital for patient health and therapeutic efficacy.

Purpose of the Study:

• To investigate the effect of phenytoin on zinc absorption in a rodent model.
• To determine if phenytoin influences the net absorption of orally administered zinc.
• To quantify the dose-dependent effects of phenytoin on zinc bioavailability.

Main Methods:

• Groups of rats were administered phenytoin daily at doses of 10, 50, and 100 mg for 10 days.
• A single oral dose of radioactive zinc (65Zn) was administered to the rats.
• Whole-body counting was used to measure 65Zn retention, enabling calculation of net zinc absorption.

Main Results:

• All tested doses of phenytoin (10, 50, and 100 mg/day) significantly increased zinc absorption in rats.
• A clear trend indicated enhanced zinc uptake with increasing phenytoin dosage.
• The study demonstrates a significant interaction between phenytoin and zinc bioavailability.

Conclusions:

• Phenytoin administration leads to a significant enhancement of zinc absorption in rats.
• This finding suggests a potential for altered zinc status in patients taking phenytoin, warranting further investigation.
• Clinical studies are recommended to confirm these effects in humans and assess potential implications for zinc supplementation.